Breastfeeding Education Support Tool
Launched by THOMAS JEFFERSON UNIVERSITY · Jan 21, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a program called the Breastfeeding Education Support Tool for Baby (BEST4Baby), which aims to help mothers in India with breastfeeding. The goal is to see if this program, which includes support from trained peer counselors, can improve how well mothers breastfeed their babies and support their overall development. This is important because many mothers in India still face challenges with breastfeeding, and if this program works well, it could be adopted in other places to help more mothers and babies.
To participate in this study, mothers need to be at least 18 years old and pregnant, between 20 and 27 weeks along in their pregnancy. They should be expecting one baby and must not have serious health issues that could affect breastfeeding. Participants will receive visits from peer counselors and researchers for up to a year after their baby is born to provide support and gather information. It’s a great opportunity for mothers to receive help while also contributing to important research that could benefit many families.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • at least 18 years of age,
- • pregnant and 20-27 weeks of gestation at study enrollment,
- • singleton pregnancy,
- • no major antepartum complications,
- • living in a research site,
- • planning to deliver in the cluster area,
- • capable of giving informed consent,
- • willing to be visited by a PC and research personnel for up to 12 months post-delivery.
- Exclusion Criteria:
- • comorbidities impacting breastfeeding,
- • - severe psychological illness that could interfere with consent and study participation. Following a live birth, participants will remain eligible to continue in the study unless the mother or infant experiences: illness or clinical complications warranting prolonged hospitalization, stillbirth, low birth weight (\< 2500 g), congenital abnormality, or neonatal death.
About Thomas Jefferson University
Thomas Jefferson University is a distinguished academic institution located in Philadelphia, Pennsylvania, renowned for its commitment to advancing healthcare through research and education. As a clinical trial sponsor, the university leverages its extensive resources and interdisciplinary expertise to conduct innovative research aimed at improving patient outcomes. With a focus on translational medicine, Thomas Jefferson University collaborates with various stakeholders, including healthcare professionals, industry partners, and regulatory agencies, to ensure the highest standards of scientific rigor and ethical conduct in its clinical trials. The institution is dedicated to fostering a culture of excellence in research, ultimately contributing to the advancement of medical knowledge and the development of novel therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Belgaum, Karnataka, India
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported